DK1275638T3 - Kombinationspræparat til behandling af immunologiske sygdomme - Google Patents

Kombinationspræparat til behandling af immunologiske sygdomme

Info

Publication number
DK1275638T3
DK1275638T3 DK02013275T DK02013275T DK1275638T3 DK 1275638 T3 DK1275638 T3 DK 1275638T3 DK 02013275 T DK02013275 T DK 02013275T DK 02013275 T DK02013275 T DK 02013275T DK 1275638 T3 DK1275638 T3 DK 1275638T3
Authority
DK
Denmark
Prior art keywords
combination preparation
treatment
immunological diseases
biosynthesis inhibitor
precursor
Prior art date
Application number
DK02013275T
Other languages
Danish (da)
English (en)
Inventor
Juergen Dr Lindner
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK1275638T3 publication Critical patent/DK1275638T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DK02013275T 2001-07-06 2002-06-18 Kombinationspræparat til behandling af immunologiske sygdomme DK1275638T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10132308A DE10132308A1 (de) 2001-07-06 2001-07-06 Kombinationspräparat zur Therapie von immunologischen Erkrankungen

Publications (1)

Publication Number Publication Date
DK1275638T3 true DK1275638T3 (da) 2006-10-16

Family

ID=7690511

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02013275T DK1275638T3 (da) 2001-07-06 2002-06-18 Kombinationspræparat til behandling af immunologiske sygdomme

Country Status (10)

Country Link
US (1) US20030017166A1 (ja)
EP (1) EP1275638B1 (ja)
JP (1) JP2003063995A (ja)
KR (1) KR20030005042A (ja)
AT (1) ATE329898T1 (ja)
CA (1) CA2392187A1 (ja)
DE (2) DE10132308A1 (ja)
DK (1) DK1275638T3 (ja)
ES (1) ES2265007T3 (ja)
PT (1) PT1275638E (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060205682A1 (en) * 2005-02-25 2006-09-14 Roberts Richard H Antibiotic and combinations of antibiotic and symptomatic relief agent formulations
CN101675040A (zh) 2007-05-03 2010-03-17 辉瑞有限公司 作为钠通道调节剂的2-吡啶甲酰胺衍生物
CN104080408B (zh) * 2012-11-21 2016-06-01 株式会社东芝 超声波诊断装置、图像处理装置以及图像处理方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL186239B (nl) * 1975-06-05 Hoechst Ag Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze.
US4565696A (en) * 1983-08-03 1986-01-21 The Regents Of The University Of California Production of immunogens by antigen conjugation to liposomes
US5747034A (en) * 1992-07-09 1998-05-05 Chiron Corporation Methods and materials for the induction of T cell anergy
DK0945465T3 (da) * 1992-07-09 2007-01-15 Novartis Vaccines & Diagnostic Antagonistiske monoklonale antistoffer mod humant CD40
JPH06298654A (ja) * 1993-04-12 1994-10-25 Sumitomo Electric Ind Ltd 抗原特異的免疫抑制剤
AU3980595A (en) * 1994-11-10 1996-06-06 Cellena (Cell Engineering) A.G. Composition containing pooled transferrins as an active principle for the induction of immune tolerance against antigens
ATE259235T1 (de) * 1995-07-20 2004-02-15 Cell Eng Ag Zubereitung enthaltend glykane übereinstimmend mit transferrin glykaner als aktives prinzip für die induktion der immuntoleranz gegen antigene
EP2002846B1 (en) * 1996-12-06 2017-01-25 Amgen Inc. Combination therapy using an IL-1 inhibitor for treating IL-1 mediated diseases
DE69724451T2 (de) * 1996-12-06 2004-03-18 Amgen Inc., Thousand Oaks Kombinationtherapie mit einem tnf-bindendem protein zür behandlung von durch tnf verursachten erkrangungen
US5935577A (en) * 1998-01-23 1999-08-10 Autoimmune Inc. Treatment of autoimmune disease using tolerization in combination with methotrexate

Also Published As

Publication number Publication date
DE10132308A1 (de) 2003-01-30
JP2003063995A (ja) 2003-03-05
EP1275638A1 (de) 2003-01-15
EP1275638B1 (de) 2006-06-14
KR20030005042A (ko) 2003-01-15
DE50207168D1 (de) 2006-07-27
CA2392187A1 (en) 2003-01-06
US20030017166A1 (en) 2003-01-23
PT1275638E (pt) 2006-09-29
ES2265007T3 (es) 2007-02-01
ATE329898T1 (de) 2006-07-15

Similar Documents

Publication Publication Date Title
ATE360706T1 (de) Peptidakzeptor ligationsverfahren
NO20050795L (no) Forbindelser, blandinger og fremgangsmater for utnyttelse av samme
DK0966447T3 (da) Anvendelige små molekyler til behandling af betændelsessygdomme
CY1106357T1 (el) Παραγωγα αδαμαντανιου για τη θepαπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων
AU2002310187A1 (en) Inhibitors of protein kinase for the treatment of disease
WO1999057280A3 (en) Neisseria meningitidis antigens and compositions
WO2004007743A3 (en) Use of cpg nucleic acids in prion-disease
CY1113243T1 (el) Μεθοδοι θεραπειας με χρηση αντισωματων cτlα-4
ATE337007T1 (de) Harnstoffsubstituierte imidazochinoline
ITMI20011986A0 (it) Metodo e composizione per l'attivazione di cellule presentanti l'antigene
DK1303632T3 (da) Galactomannan-oligosaccharid og fremgangsmåde til fremstilling samt anvendelse heraf
WO2001058485A3 (en) Prophylactic and therapeutic antibodies against vaccina virus antigens
WO2003104425A3 (en) NEW STABLE ANTI-CD22 ANTIBODIES
MXPA03006817A (es) Metodo de tratamiento de enfermedades inflamatorias e inmunes usando inhibidores de la ikb cinasa (ikk).
WO2003010291A3 (en) Treatment of immune disorders and b cell disorders
ITMI20031819A1 (it) Dispositivo per la lavorazione di pezzi sostanzialmente piatti.
WO2002068476A3 (en) Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders
DK1275638T3 (da) Kombinationspræparat til behandling af immunologiske sygdomme
NO20035136D0 (no) Fremgangsmåte til fremstilling av imipenem
DK1245565T3 (da) Indenoindolon-forbindelse, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
UA83989C2 (ru) Выделенный пептид, который стимулирует противоопухолевый иммунный ответ, фармацевтическая композиция на его основе и ее применение
ATE444762T1 (de) Therapeutische zusammenseztungen zur toleranzinduktion
BR0211196A (pt) Uso de derivados de fenila, fenol e benzoìla trifluoracetilalquila-substituìdos no tratamento e/ou na profilaxia da obesidade e suas doenças associadas e/ou decorrentes
WO2004017902A3 (en) Ubiquitin and ubiquitin related molecules for treatment and prevention of harmful activation of the immune system
WO2002085312A3 (en) Process for purifying 6-methoxy omeprazole